Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

AbbVie (ABBV) Q3 2023 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg
AbbVie (ABBV) Q3 2023 Earnings Call Transcript

Image source: The Motley Fool.

AbbVie (NYSE: ABBV)Q3 2023 Earnings CallOct 27, 2023, 9:00 a.m. ET

Operator

Continue reading

Source Fool.com

2 Green Flags and 1 Red Flag for Novartis Stock: https://g.foolcdn.com/editorial/images/752126/scientists-high-five-smile.jpg
2 Green Flags and 1 Red Flag for Novartis Stock

Share prices of Swiss pharmaceutical company Novartis (NYSE: NVS) have climbed more than 10% so far this year. The company focuses on cardiovascular, immunology, neuroscience, solid tumors, and

Why Blueprint Medicines Stock Soared Today: https://g.foolcdn.com/editorial/images/752482/doctors-office-medical-equipment-brightly-colored.jpg
Why Blueprint Medicines Stock Soared Today

Shares of Blueprint Medicines (NASDAQ: BPMC) closed up 25.6% on Thursday after the cancer and blood discorder therapy company announced stronger-than-expected quarterly results.

Blueprint Medicines'

Why Novocure Stock Was Sick Today: https://g.foolcdn.com/editorial/images/752492/two-people-seated-at-a-lab-desk-featuring-a-pc-screen-and-microscope.jpg
Why Novocure Stock Was Sick Today

Oncology-focused healthcare company Novocure (NASDAQ: NVCR) wasn't much of a cure for anyone's ill finances on Thursday. Its share price dived by nearly 8% on the day after management released its

Merck (MRK) Q3 2023 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg
Merck (MRK) Q3 2023 Earnings Call Transcript

Image source: The Motley Fool.

Merck (NYSE: MRK)Q3 2023 Earnings CallOct 26, 2023, 9:00 a.m. ET

Operator

Continue reading

Source Fool.com

2 Best Healthcare Stocks to Buy Right Now: https://g.foolcdn.com/editorial/images/752016/couple-financial-review-papers-bills-personal-finance-investing.jpg
2 Best Healthcare Stocks to Buy Right Now

The healthcare industry may not be as hot with investors as artificial intelligence or other high-flying industries, but the range of essential needs these businesses serve provides opportunities

Got $1,000? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond: https://g.foolcdn.com/editorial/images/752023/physician-shaking-patients-hand.jpg
Got $1,000? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond

While equity markets this year have recovered some of ground lost from the plunge of 2022, plenty of companies are still struggling. Some of them, though, clearly have the tools to rebound

3 Pharma Stocks That Are Screaming Buys in October: https://g.foolcdn.com/editorial/images/751916/scientists-in-a-lab.jpg
3 Pharma Stocks That Are Screaming Buys in October

It hasn't been the easiest of years for Johnson & Johnson (NYSE: JNJ), Amgen (NASDAQ: AMGN) and Gilead Sciences (NASDAQ: GILD). Shares of all three healthcare companies are trading flat or down amid

Vertex Pharmaceuticals: Buy at the High?: https://g.foolcdn.com/editorial/images/752204/gettyimages-613345556.jpg
Vertex Pharmaceuticals: Buy at the High?

Vertex Pharmaceuticals (NASDAQ: VRTX) has climbed in the double digits this year and is trading around its highest ever. There are plenty of reasons for this top performance. The company continues

3 Healthcare Stocks to Buy and Hold for the Next 10 Years: https://g.foolcdn.com/editorial/images/752060/senior-social-security-home-banking-tablet.jpg
3 Healthcare Stocks to Buy and Hold for the Next 10 Years

It hasn't been the easiest time for investors across a range of industries and sectors over the last few years. The good news is that when you're buying stocks to hold onto for anywhere from five

Why Alkermes Stock Is Sinking Today: https://g.foolcdn.com/editorial/images/752236/scientists-looking-at-brain-scans.jpg
Why Alkermes Stock Is Sinking Today

Shares of Alkermes (NASDAQ: ALKS) were sinking 7.9% as of 11:58 a.m. ET on Wednesday and had fallen as much as 13.1% earlier in the session. The decline came after the Ireland-based drugmaker

Should Dividend Stock Investors Buy AT&T Stock Right Now?: https://g.foolcdn.com/editorial/images/752227/person-looking-at-phone.jpg
Should Dividend Stock Investors Buy AT&T Stock Right Now?

Fool.com contributor Parkev Tatevosian reviews AT&T's (NYSE: T) latest quarterly update and lets you know if passive income investors should buy the stock.

*Stock prices used were the afternoon

Stock-Split Watch: Could These 2 Growth Stocks Be Next?: https://g.foolcdn.com/editorial/images/751649/person-sitting-at-a-desk-looking-at-two-monitors.jpg
Stock-Split Watch: Could These 2 Growth Stocks Be Next?

Over the past few years, we have witnessed several high-profile stock splits. Of course, these moves don't fundamentally change the value of a corporation. However, they can generate some buzz and

3 Red-Hot Growth Stocks That Are Still Cheap Buys: https://g.foolcdn.com/editorial/images/751836/an-excited-investor-looking-at-a-chart.jpg
3 Red-Hot Growth Stocks That Are Still Cheap Buys

Are you looking for some exciting growth stocks to put in your portfolio? While some stocks may have risen to absurd valuations, there are still deals out there, especially for long-term investors

Pfizer's Dividend Yield Is Now 5%. Is the Stock a No-Brainer Buy for Income Investors?: https://g.foolcdn.com/editorial/images/751841/doctor-giving-a-patient-medication.jpg
Pfizer's Dividend Yield Is Now 5%. Is the Stock a No-Brainer Buy for Income Investors?

Did you know that if you have a high-yielding dividend stock that pays 5%, investing just $20,000 would be enough to generate $1,000 in annual dividend income? High-yielding stocks can be extremely

2 Biotech Stocks You Can Buy and Hold for the Next Decade: https://g.foolcdn.com/editorial/images/751595/patient-sitting-on-hospital-bed.jpg
2 Biotech Stocks You Can Buy and Hold for the Next Decade

There is no denying that the biotech industry can be pretty risky and volatile, but there are also advantages to investing in stocks in this sector. First, there is always a need for innovative

AT&T Stock Just Proved Why It's One of the Best Dividend Stocks to Own Right Now: https://g.foolcdn.com/editorial/images/751644/gettyimages-1213293717.jpg
AT&T Stock Just Proved Why It's One of the Best Dividend Stocks to Own Right Now

Consumers have virtually no shortage when it comes to telecommunications providers. Whether it's Verizon, T-Mobile, or AT&T (NYSE: T), people are barraged with a recurring carousel of commercials

Is BioNTech Stock a Buy Now?: https://g.foolcdn.com/editorial/images/751618/doctor-vaccinating-a-patient.jpg
Is BioNTech Stock a Buy Now?

BioNTech (NASDAQ: BNTX) is the lesser-known member of the pair -- which also includes Pfizer -- that developed and marketed Comirnaty, one of the leading coronavirus vaccines on the market. However

Better Stock Buy: AT&T vs. C3.ai: https://g.foolcdn.com/editorial/images/752007/young-trader-at-home.jpg
Better Stock Buy: AT&T vs. C3.ai

AT&T (NYSE: T) and C3.ai (NYSE: AI) generally appeal to different types of tech investors. AT&T, one of the largest telecom companies in America, is usually owned for stability and dividends instead

EQS-News: MorphoSys Reports Preliminary Q3 2023 Monjuvi U.S. Sales and Gross Margin, and Updates Financial Guidance for 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-News: MorphoSys Reports Preliminary Q3 2023 Monjuvi U.S. Sales and Gross Margin, and Updates Financial Guidance for 2023
EQS-News: MorphoSys Reports Preliminary Q3 2023 Monjuvi U.S. Sales and Gross Margin, and Updates Financial Guidance for 2023
EQS-Adhoc: Ad hoc: MorphoSys AG Reports Preliminary Q3 2023 Monjuvi U.S. Sales and Gross Margin, and Updates Financial Guidance for 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-Adhoc: Ad hoc: MorphoSys AG Reports Preliminary Q3 2023 Monjuvi U.S. Sales and Gross Margin, and Updates Financial Guidance for 2023
EQS-Adhoc: Ad hoc: MorphoSys AG Reports Preliminary Q3 2023 Monjuvi U.S. Sales and Gross Margin, and Updates Financial Guidance for 2023
Novartis Ag (NVS) Q3 2023 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg
Novartis Ag (NVS) Q3 2023 Earnings Call Transcript

Image source: The Motley Fool.

Novartis Ag (NYSE: NVS)Q3 2023 Earnings CallOct 24, 2023, 8:00 a.m. ET

Operator

Continue reading

Source Fool.com

Why LianBio Stock Is Skyrocketing Today: https://g.foolcdn.com/editorial/images/752037/scientists-asian.jpg
Why LianBio Stock Is Skyrocketing Today

Shares of LianBio (NASDAQ: LIAN) were skyrocketing 132.4% higher as of 11:11 a.m. ET on Tuesday. The huge gain came after the company announced that it entered into an agreement to hand over

Abbott Laboratories May Soon Launch a Game-Changing New Device in the U.S.: https://g.foolcdn.com/editorial/images/751839/a-doctor-looking-at-a-tablet-with-another-person.jpg
Abbott Laboratories May Soon Launch a Game-Changing New Device in the U.S.

Abbott Laboratories (NYSE: ABT) has been a disappointing investment in recent years. While COVID-19 testing gave the business a boost, this has largely been a slow-growing company. And since 2020

The Best Stocks to Invest $5,000 In Right Now: https://g.foolcdn.com/editorial/images/751878/gettyimages-103919680.jpg
The Best Stocks to Invest $5,000 In Right Now

Bear markets and bull markets come and go, so it's best to avoid building your portfolio around one specific market phase. Instead, pick up shares of companies with potential to grow your wealth